المؤلفون: Simona Soverini, Manuela Mancini, Luana Bavaro, Michele Cavo, Giovanni Martinelli

المصدر: Molecular Cancer, Vol 17, Iss 1, Pp 1-15 (2018)

مصطلحات موضوعية: BCR-ABL1, Tyrosine kinase, Tyrosine kinase inhibitors, Resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1186/s12943-018-0780-6Test; https://doaj.org/toc/1476-4598Test

الوصول الحر: https://doaj.org/article/20b226ea95774f068eed7f00d2a46eafTest

المؤلفون: Manuela Mancini, Michele Cavo, Giovanni Martinelli, Simona Soverini, Luana Bavaro

المساهمون: Soverini, Simona, Mancini, Manuela, Bavaro, Luana, Cavo, Michele, Martinelli, Giovanni

المصدر: Molecular Cancer, Vol 17, Iss 1, Pp 1-15 (2018)
Molecular Cancer

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.drug_class, Population, Resistance, Tyrosine kinase inhibitor, Protein Kinase Inhibitor, Drug resistance, Review, Biology, lcsh:RC254-282, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, medicine, Animals, Humans, education, Protein Kinase Inhibitors, Tyrosine kinase, Tyrosine kinase inhibitors, education.field_of_study, Animal, Myeloid leukemia, Cancer, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, BCR-ABL1, 030104 developmental biology, Imatinib mesylate, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, Imatinib Mesylate, Molecular Medicine, Magic bullet, Human, Signal Transduction

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23a85586da3de9479777d81f01bed1ddTest
http://link.springer.com/article/10.1186/s12943-018-0780-6Test

المؤلفون: Soverini, Simona, Mancini, Manuela, Bavaro, Luana, Cavo, Michele, Martinelli, Giovanni

المصدر: Molecular Cancer; 2/19/2018, Vol. 17, p1-1, 1p, 5 Diagrams, 2 Charts

مصطلحات موضوعية: TREATMENT of chronic myeloid leukemia, TARGETED drug delivery, PROTEIN-tyrosine kinases, DRUG resistance in cancer cells, CANCER treatment